Company History

2001

  • Universal Biosensors, Inc (UBI) incorporated in Delaware, US.
  • Australian subsidiary, Universal Biosensors Pty Ltd, formed.

2002

  • UBI completes deal with LifeScan, Inc, (a Johnson & Johnson company).
  • LifeScan takes ownership of electrochemical cell technologies and grants UBI a licence for these technologies outside the field of diabetes and blood glucose management generally.
  • LifeScan engages UBI to develop a new blood glucose test.

2006

  • UBI lists on the Australian Securities Exchange.
  • UBI commences establishment of world class biosensor manufacturing facilities at Rowville, Victoria, Australia.

2009

  • LifeScan’s UBI-designed biosensor strip and meter system, OneTouch® Verio®, receives initial regulatory clearance to sell in Europe. The product has since been rolled out globally.

2012

  • UBI signs long term supply and manufacturing agreement with Siemens Healthcare Diagnostics for manufacture of biosensors for point-of-care (POC) coagulation testing.

2014

  • Siemens Healthcare Diagnostics receives CE Mark approval and launches the Xprecia StrideTM Coagulation Analyser in Europe.